BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28453560)

  • 21. PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma.
    Li HG; Liu FF; Zhu HQ; Zhou X; Lu J; Chang H; Hu JH
    Int J Clin Exp Pathol; 2015; 8(11):15255-9. PubMed ID: 26823876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.
    Bi J; Zhong C; Li K; Chu H; Wang B
    Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional polymorphisms of the cyclooxygenase-2 gene and prognosis of hepatocellular carcinoma - a cohort study in Chinese people.
    Liang R; Yan XX; Lin Y; Li Q; Yuan CL; Liu ZH; Li YQ
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.
    Qu K; Liu SS; Wang ZX; Huang ZC; Liu SN; Chang HL; Xu XS; Lin T; Dong YF; Liu C
    World J Gastroenterol; 2015 Apr; 21(14):4310-22. PubMed ID: 25892883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population.
    Deng Y; Chen ZJ; Lan F; He QT; Chen SY; Du YF; Li S; Qin X
    J Clin Lab Anal; 2019 Oct; 33(8):e22977. PubMed ID: 31301090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
    Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation.
    Wu LM; Zhou L; Xu J; Wei BJ; Cheng J; Xu X; Xi B; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):54-9. PubMed ID: 23392799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Med Oncol; 2014 Dec; 31(12):301. PubMed ID: 25367853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
    Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
    Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese.
    Shi Y; Zhai W; Wang B; Zhao D; Jin H; Wang Y; Zhang J; An H; Fu Z; Zhao K; Lu C
    Oncotarget; 2016 Dec; 7(49):80935-80942. PubMed ID: 27821814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival.
    Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
    J Hepatol; 2012 Sep; 57(3):621-7. PubMed ID: 22659345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
    Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
    Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery.
    Guo X; Li D; Chen Y; An J; Wang K; Xu Z; Chen Z; Xing J
    Sci Rep; 2015 Jun; 5():11846. PubMed ID: 26115041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population.
    Luo HC; Zhang HB; Xin XJ; Huang WX
    Tumour Biol; 2014 Apr; 35(4):3415-9. PubMed ID: 24307625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 40. CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
    Costa EFD; Lopes-Aguiar L; Nogueira GS; Lima TRP; Rinck-Junior JA; Lourenço GJ; Lima CSP
    Head Neck; 2019 Aug; 41(8):2665-2670. PubMed ID: 30903678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.